Indication: ENERZAIR BREEZHALER is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long-acting beta2-agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.1
Please contact a Novartis representative to order this material.
Reference
- ENERZAIR BREEZHALER Summary of Product Characteristics.